Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 3
1988 4
1989 4
1990 1
1991 1
1992 4
1993 2
1994 2
1995 2
1996 1
1997 2
1998 2
1999 2
2000 6
2001 5
2002 1
2003 4
2004 3
2005 3
2006 2
2007 4
2008 2
2010 6
2011 6
2012 6
2013 4
2014 3
2015 2
2016 6
2017 5
2018 6
2019 7
2020 2
2021 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial.
Chaganti S, Maycock S, McIlroy G, Jackson A, Bishop R, Johnson S, Kanfer E, Kassam S, Cwynarski K, Wrench D, Arumainathan A, Fox CP, Johnson R, McKay P, Paneesha S, Rowntree C, Balotis C, Collins GP, Davies A, Wright J, Burns S, Laurence A, Wheatley K, Menne T. Chaganti S, et al. Among authors: kanfer e. Blood. 2024 Jul 25;144(4):392-401. doi: 10.1182/blood.2024023847. Blood. 2024. PMID: 38643491 Clinical Trial.
Hypogammaglobulinaemia after rituximab treatment-incidence and outcomes.
Makatsori M, Kiani-Alikhan S, Manson AL, Verma N, Leandro M, Gurugama NP, Longhurst HJ, Grigoriadou S, Buckland M, Kanfer E, Hanson S, Ibrahim MA, Grimbacher B, Chee R, Seneviratne SL. Makatsori M, et al. Among authors: kanfer e. QJM. 2014 Oct;107(10):821-8. doi: 10.1093/qjmed/hcu094. Epub 2014 Apr 28. QJM. 2014. PMID: 24778295
Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival.
Galleu A, Milojkovic D, Deplano S, Szydlo R, Loaiza S, Wynn R, Marks DI, Richardson D, Orchard K, Kanfer E, Tholouli E, Saif M, Sivaprakasam P, Lawson S, Bloor A, Pagliuca A, Potter V, Mehra V, Snowden JA, Vora A, Kishore B, Hunter H, Apperley JF, Dazzi F. Galleu A, et al. Among authors: kanfer e. Br J Haematol. 2019 Apr;185(1):89-92. doi: 10.1111/bjh.15749. Epub 2019 Jan 13. Br J Haematol. 2019. PMID: 30637732 Free PMC article.
Hepatosplenic T cell lymphoma in inflammatory bowel disease.
Shale M, Kanfer E, Panaccione R, Ghosh S. Shale M, et al. Among authors: kanfer e. Gut. 2008 Dec;57(12):1639-41. doi: 10.1136/gut.2008.163279. Epub 2008 Jul 30. Gut. 2008. PMID: 18667489 No abstract available.
Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation.
Innes AJ, Mullish BH, Ghani R, Szydlo RM, Apperley JF, Olavarria E, Palanicawandar R, Kanfer EJ, Milojkovic D, McDonald JAK, Brannigan ET, Thursz MR, Williams HRT, Davies FJ, Marchesi JR, Pavlů J. Innes AJ, et al. Among authors: kanfer ej. Front Cell Infect Microbiol. 2021 Aug 27;11:684659. doi: 10.3389/fcimb.2021.684659. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34513724 Free PMC article.
103 results